Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    dksh-m-2025-05-26

    Virtual Booth

    Contact Supplier

    dmfs-not-supported-m-2025-05-19

    Virtual Booth

    An Enquiry

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    LEBSA- Your strategic API source for niche molecules.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Sodium Lauryl Sulfate

    INACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1ALPRAZOLAM

    02 1CLONAZEPAM

    03 3OLANZAPINE

    04 4RISPERIDONE

    05 1SUPRENZA

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    Left Arrow
    Right Arrow
    ListList of Suppliers

    01

    ACTAVIS ELIZABETH

    ALPRAZOLAM

    arrow
    GRx+Biosims
    Not Confirmed
    ACTAVIS ELIZABETH
    Ireland
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    ALPRAZOLAM

    Drug : ALPRAZOLAM

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 78561

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AJANTA PHARMA LTD

    OLANZAPINE

    arrow
    GRx+Biosims
    Not Confirmed
    AJANTA PHARMA LTD
    India
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OLANZAPINE

    Drug : OLANZAPINE

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 204320

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    CITIUS PHARMS

    PHENTERMINE HYDROCHLORIDE

    arrow
    GRx+Biosims
    Not Confirmed
    CITIUS PHARMS
    U.S.A
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    PHENTERMINE HYDROCHLORIDE

    Drug : SUPRENZA

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 202088

    Country : US

    Patented : Yes

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    DASH PHARMS

    RISPERIDONE

    arrow
    GRx+Biosims
    Not Confirmed
    DASH PHARMS
    U.S.A
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RISPERIDONE

    Drug : RISPERIDONE

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 91537

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    ENDO OPERATIONS

    CLONAZEPAM

    arrow
    GRx+Biosims
    Not Confirmed
    ENDO OPERATIONS
    Ireland
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    CLONAZEPAM

    Drug : CLONAZEPAM

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 77171

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    JUBILANT GENERICS

    RISPERIDONE

    arrow
    Pharmacy Expo
    Not Confirmed
    JUBILANT GENERICS
    India
    arrow
    Pharmacy Expo
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RISPERIDONE

    Drug : RISPERIDONE

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 90839

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    NORVIUM BIOSCIENCE

    OLANZAPINE

    arrow
    GRx+Biosims
    Not Confirmed
    NORVIUM BIOSCIENCE
    U.S.A
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OLANZAPINE

    Drug : OLANZAPINE

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 202285

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    SUN PHARM INDS LTD

    RISPERIDONE

    arrow
    GRx+Biosims
    Not Confirmed
    SUN PHARM INDS LTD
    India
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RISPERIDONE

    Drug : RISPERIDONE

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 78464

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    DR REDDYS LABS LTD

    RISPERIDONE

    arrow
    GRx+Biosims
    Not Confirmed
    DR REDDYS LABS LTD
    Gabon
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    RISPERIDONE

    Drug : RISPERIDONE

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 77328

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    DR REDDYS LABS LTD

    OLANZAPINE

    arrow
    GRx+Biosims
    Not Confirmed
    DR REDDYS LABS LTD
    Gabon
    arrow
    GRx+Biosims
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    OLANZAPINE

    Drug : OLANZAPINE

    Dosage Form : TABLET, ORALLY DISINTEGRATING; ORAL

    Application Number : 76534

    Country : US

    Patented : No

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF